Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cytokine and Growth Factor Reviews is Scopus-indexed (Q1, CiteScore 21.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 1359-6101Verify ISSN ↗1879-0305Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$4,900 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 9 / 250 | 96th | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 9 / 223 | 96th | Q1 |
| Immunology and Allergy | 12 / 234 | 95th | Q1 |
| Immunology | 14 / 243 | 94th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q1, CiteScore 21.8.
Cytokine and Growth Factor Reviews is Q1 in Endocrinology, Diabetes and Metabolism (rank 9 of 250), Q1 in Biochemistry, Genetics and Molecular Biology (all) (rank 9 of 223) and Q1 in Immunology and Allergy (rank 12 of 234), by CiteScore 2025. It is ranked in 4 subject areas in all.
Cytokine and Growth Factor Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 21.8, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.297, quartile Q1, with an H-index of 193.
The publisher lists an article processing charge of about US$4,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cytokine and Growth Factor Reviews is published by Elsevier Ltd. Its print ISSN is 1359-6101 and its online ISSN is 1879-0305.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cytokine and Growth Factor Reviews has an h-index of 207 and a 2-year mean of 13.28 citations per paper (OpenAlex). Its Scopus CiteScore is 21.8, quartile Q1. On 2-year citations it ranks #8 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Cytokine and Growth Factor Reviews published 77 papers in 2025; its busiest recent year was 2020 with 83. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (30.3%), United States (24.4%) and India (13.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.